What the American Kratom Association Actually Does — and Where Its Authority Ends

Kratom sits in an odd regulatory spot. It’s sold legally across most of the country, used by hundreds of thousands of adults, and yet has no federal approval process, no mandatory testing rules, and no agency checking labels for accuracy. Into that gap stepped a nonprofit called the American Kratom Association (AKA). It runs the industry’s most widely recognized quality program — but it’s not a government body, and it can’t approve products, certify lab results, or enforce federal law.

Understanding what the AKA actually does — and doesn’t do — matters if you’re trying to figure out which vendors are worth trusting. This piece breaks down the organization’s role, its Good Manufacturing Practices (GMP) program, the audit process behind it, and the limits of what any of it can guarantee.

What Is the American Kratom Association?

The AKA was founded in 2014 as a 501(c)(4) advocacy nonprofit representing kratom consumers and vendors in the U.S. Its stated goal is to keep kratom legal and available while pushing the market toward safer, more transparent practices.

The organization works in three main areas:

• Advocacy — lobbying state legislatures to pass consumer protection laws and engaging federal agencies like the DEA, FDA, and HHS on scheduling and policy decisions
• Public education — publishing material on kratom’s pharmacology and legal status, and responding to media coverage of adverse events
• Industry standards — running the AKA GMP Standards Program, a voluntary manufacturing-quality certification that has become the closest thing the industry has to a benchmark

The clearest example of the AKA’s influence came in 2016, when the DEA announced plans to place kratom’s active compounds into Schedule I on an emergency basis. The AKA organized public comment campaigns and congressional outreach that contributed to the DEA withdrawing that notice later that year — a rare reversal for the agency once it’s issued a scheduling notice.

None of this makes the AKA a regulator. It doesn’t license manufacturers, test products, or issue medical guidance. It’s an advocacy group that also happens to run a quality-standards program.

Why a Nonprofit Ended Up Filling a Regulatory Gap

Dietary supplements in the U.S. are governed by the Dietary Supplement Health and Education Act of 1994, which gives the FDA authority to act after a problem shows up — not before a product hits shelves. Supplements aren’t pre-approved for safety. The FDA can pull one after the fact if it’s found to be adulterated or mislabeled.

Kratom doesn’t even get that much oversight. The FDA has consistently said it doesn’t consider kratom a lawful dietary supplement, and it has issued warning letters and import alerts to vendors since 2014. So while kratom is sold openly in most states and used by an estimated 1.7 million adults, according to federal survey data, there’s no pre-market approval process, no required manufacturing standard, and no mandatory testing regime specific to the plant.

That vacuum created real problems, and they’re well documented:

• Synthetic adulteration — research published in 2016 found commercial kratom products containing 7-hydroxymitragynine at concentrations far higher than what whole-leaf processing could produce, pointing to spiking with a synthetic version of the compound
• Salmonella contamination — a multistate outbreak investigated by the CDC between 2017 and 2018 was linked to kratom products and resulted in nearly 200 confirmed illnesses across dozens of states
• Heavy metals — independent testing has turned up lead and nickel above acceptable levels in some imported material, a reflection of inconsistent sourcing and soil quality with no federal testing requirement to catch it
• Inaccurate labeling — products marketed under different strain names have shown up chemically indistinguishable in lab analysis, and alkaloid claims on labels have often exceeded what batches actually contained
• Undisclosed additives — some products sold as kratom have tested positive for other psychoactive substances, including tianeptine and O-desmethyltramadol, without disclosure

The AKA GMP program was built directly in response to these failures. Its audit checklist maps closely onto each problem listed above. A 2024 review in Frontiers in Pharmacology on kratom safety and regulation argued that the evidence base now supports formal, supplement-style oversight — which is essentially what the AKA GMP program, paired with state legislation, is trying to approximate in the absence of federal rules.

The AKA GMP Standards Program Explained

The AKA GMP Standards Program is a voluntary certification. Vendors who want to be listed as “AKA GMP Qualified” submit to a third-party audit measured against a written standard covering everything from raw material intake to finished-product shipping.

Two things make up the program: the written standard itself, published by the AKA, and the audit process, carried out by outside auditing firms that aren’t employed by the AKA.

Category	Required Practices	How It’s Verified
Facility and sanitation	Dedicated processing space, pest control, cleaning logs, air quality checks	On-site inspection
Raw material sourcing	Supplier vetting, incoming material COAs, quarantine until tested	Records and sample review
Testing	Third-party testing of every batch for microbials, heavy metals, alkaloid content	COA and lab accreditation review
Traceability	Lot coding and full farm-to-finished-product documentation	Random lot traceback during audit
Labeling	No unapproved health claims, accurate strain and alkaloid disclosure	Label checked against COA data
Age verification	21+ checkout verification, no sales in restricted states	Website and checkout review
Staff training	Documented training on GMP and sanitation procedures	Records and interviews
Recall handling	Written recall plan, adverse-event intake process, retained samples	Mock recall exercise
Prohibited products	No synthetic 7-HMG isolates, no undisclosed blends	Product line review, spot testing

This isn’t a loose “we care about quality” pledge — it’s a written, pass/fail standard built specifically around the failures the industry had already documented.

Inside an AKA GMP Audit

The audit process runs through several stages:

Application and paperwork review. A vendor submits facility specs, standard operating procedures, sourcing records, lab accreditation documents, and sample COAs. The AKA reviews this before scheduling an on-site visit.

On-site audit. The AKA doesn’t audit its own applicants. Independent firms — typically companies experienced in food and supplement manufacturing audits — spend one to two days inspecting the facility, reviewing records, interviewing employees, and tracing randomly selected lots back through the supply chain.

Findings and corrective action. Any gaps get documented. Minor issues usually require a written fix within a set window. Major issues can delay or block qualification entirely until resolved. The AKA has removed vendors from its list in the past after re-audits turned up unresolved problems.

Listing. Once a vendor passes and closes out any corrective actions, it appears on the AKA’s public list of qualified vendors. Qualification is typically renewed annually, with a fresh audit required each time.

The program isn’t a rubber stamp. Auditors have flagged things as minor as a gap in cleaning-log timestamps and as substantive as labeling language that didn’t match lab results. The point isn’t that nothing ever gets flagged — it’s that when something does, there’s a paper trail and a required fix.

The Kratom Consumer Protection Act (KCPA)

The AKA’s biggest legislative push is the Kratom Consumer Protection Act, model legislation meant for state adoption. KCPA sets state-level rules for labeling, testing, and sales — essentially building a regulatory framework state by state, since there isn’t one at the federal level.

Typical KCPA provisions include:

• Minimum purchase age of 21
• Mandatory batch testing for contaminants, including microbials and heavy metals
• A ban on products containing synthetic alkaloids or other undisclosed psychoactive substances
• Required disclosure of mitragynine and 7-HMG content
• Manufacturer and product registration with the state
• Enforcement through state agriculture or health departments, with civil penalties for violations

Adoption has picked up steadily since 2019. As of early 2026, the general landscape looks like this:

Status	Where	What It Means
Full KCPA enacted	Utah, Georgia, Arizona, Nevada, Oklahoma, Colorado, Virginia, West Virginia, Mississippi, Louisiana, Texas, and others (Florida partial)	Vendors must comply with state rules to sell legally
Pending legislation	Several states with active bills	Rules may change; worth tracking
Kratom banned	Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, plus some local jurisdictions	Illegal to sell or possess; KCPA doesn’t apply
No state-specific law	Remaining states	Legal but unregulated at the state level

Because AKA GMP requirements and KCPA provisions overlap so heavily, a vendor that’s already GMP-qualified is usually already compliant with KCPA rules where it applies. The two were designed to reinforce each other.

One gap worth noting: newer product categories, like ready-to-drink kratom beverages, emerged after KCPA language was originally drafted. A 2026 commentary in Public Health Reports pointed out that some of these drinks are being sold without alkaloid disclosure or age verification in states where KCPA enforcement hasn’t caught up — a reminder that both the law and the GMP standard need to keep expanding as new product formats appear.

What AKA Qualification Doesn’t Mean

It’s just as important to understand the limits of this certification as it is to understand what it covers.

It’s not FDA approval. The FDA still doesn’t recognize kratom as a lawful dietary supplement, and AKA qualification doesn’t change that. No AKA-qualified vendor can legally make therapeutic claims, and qualification offers no protection from FDA enforcement if they do.

It’s not a safety guarantee. The program verifies that a vendor follows documented procedures — it doesn’t guarantee every batch is safe for every person or that no one will have an adverse reaction. Kratom is a botanical with real pharmacological activity, and individual responses vary regardless of how well a product was manufactured. A 2023 study in Substance Abuse Treatment, Prevention, and Policy looked at the consumer-facing educational content published by AKA-qualified vendors and found significant variation in quality — a reminder that GMP qualification is about manufacturing process, not the quality of a company’s health messaging.

It’s not equivalent to USDA organic or GFSI-benchmarked food certifications. Those programs cover different scopes and have longer track records. AKA GMP is specific to the kratom industry and should be judged on those terms.

It doesn’t include lab testing. The AKA doesn’t run a lab. It verifies that a vendor uses an accredited third-party lab and acts on the results. The actual COAs come from independent testing labs, not from the AKA itself.

It’s not universal. Plenty of vendors, including some large ones, aren’t AKA GMP-qualified. That doesn’t automatically mean their products are unsafe — but it does mean there’s no independently verified process standard to point to.

How to Verify a Vendor’s AKA GMP Status

Plenty of vendor websites display an AKA GMP badge. Not all of those claims are current.

The only reliable source is the AKA’s public list of qualified vendors at americankratom.org. It shows:

• The company name, including any “doing business as” names
• The date of the most recent audit
• Current status — qualified, in process, lapsed, or decertified

If a vendor claims qualification but isn’t on that list, the claim is either outdated or false. The AKA updates the list as audits are completed, renewed, or lapse, and it has removed vendors whose qualifications weren’t renewed or who failed a follow-up audit.

A practical verification checklist:

1. Confirm the vendor’s listing on americankratom.org
2. Ask for a current batch COA showing mitragynine, 7-HMG, microbial, and heavy metal results
3. Confirm the COA comes from an ISO-accredited lab — the lab name and accreditation number should appear on the document
4. Check that the COA date matches the lot code on the product you actually received

Any one of these checks alone tells you less than all four together. AKA qualification without a current COA doesn’t verify much. A COA from a vendor with no manufacturing oversight doesn’t either. Combined, they give you a reasonably solid picture.

AKA GMP Compared to Other Certifications

AKA GMP sits alongside several other quality frameworks used in the broader supplement world, though it’s the only one built specifically for kratom.

Program	Administered By	Scope	Applies to Kratom?
AKA GMP Standards Program	American Kratom Association	Kratom-specific manufacturing and labeling	Yes — the only kratom-specific program
FDA cGMP (21 CFR 111)	FDA	Mandatory for lawful dietary supplements	Unclear application, since FDA doesn’t recognize kratom as a supplement
NSF/ANSI 173	NSF International	Supplement content verification	Rarely applied to kratom
USP Verified	U.S. Pharmacopeia	Pharmaceutical-grade verification	Not applicable to kratom
ISO 17025	Various accreditation bodies	Testing lab competence	Applies to the lab doing COA testing, not the vendor

The bottom line: AKA GMP should be evaluated as a kratom-specific standard filling a regulatory gap, not compared directly to certifications built for other product categories.